Stocktoria
BioScience Health Innovations, Inc. BHIC
BioScience Health Innovations, Inc. (BHIC) earns a Piotroski F-score of 4/9 (mixed financial health). It does not currently pay a dividend. FY2025 revenue was $5.7M at a 11.3% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
How it ranks in Services · percentile among 1013 companies
Percentile vs other Services companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 4/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Sector peers · similar-size Services companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| BHIC | BioScience Health Innovations, Inc. | 4/9 | — | — | — |
| DTCX | Datacentrex, Inc. | 4/9 | — | — | — |
| TCGLF | TechCreate Group Ltd. | 3/9 | 18.16 | — | — |
| GLE | Global Engine Group Holding Ltd | 2/9 | 8.35 | — | -94.1% |
| PHUN | Phunware, Inc. | 1/9 | -0.56 | — | — |
| HTCR | HeartCore Enterprises, Inc. | 4/9 | -1.89 | 0.8 | -70.5% |
| SHAZ | SharonAI Holdings Inc. | 2/9 | -4.35 | — | — |
About BioScience Health Innovations, Inc.
BioScience Health Innovations, Inc. operates as a health and wellness innovation company focuses on mitochondrial health science, advanced peptide delivery, and metabolic care in the United States. It offers nutritional supplements, peptides, and bioactive compounds through its core technology Mineral Oxide Delivery System, as well as provides Oracle NetSuite, an accounting and financial reporting system. The company also provides services, including testosterone and hormonal Optimization, NAD+ and cellular health, and platform licensing and peptide delivery. It sells its products through Amazon platform; and direct-to-consumer. The company was formerly known as Nowtransit Inc and changed its name to BioScience Health Innovations, Inc. in February 2025. BioScience Health Innovations, Inc. is based in Bluffdale, Utah.
FAQ
Is BHIC financially healthy?
BioScience Health Innovations, Inc.'s Piotroski F-score is 4/9 (8–9 is excellent, 0–3 weak).
Does BHIC pay a dividend?
No, BioScience Health Innovations, Inc. does not currently pay a dividend.
How profitable is BHIC?
In FY2025, BioScience Health Innovations, Inc. had a net margin of 11.3% and a return on equity of 43.5%.
Is BHIC a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on BioScience Health Innovations, Inc.: a Piotroski F-score of 4/9. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.